Minerva®-35


Sugar coated tablets
scheduling status
S4
registration number
29/21.8.2/0685
What Minerva®-35 contains
Cyproterone acetate plus ethinylestradiol.
other ingredients
Calcium carbonate precipitate Ferric oxide yellow pigment Glycerol 85 % Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Montanglycol wax Povidone 25 Povidone 700 000 Sucrose Talc Titanium dioxide.
Therapeutic classification
G03HB.
© 2026 SAHPRA. ALL RIGHTS RESERVED